Page last updated: 2024-11-04

gatifloxacin and Gastritis

gatifloxacin has been researched along with Gastritis in 1 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hori, K1
Suguro, M1
Koizuka, H1
Sakagami, T1
Tomita, T1
Kosaka, T1
Fukuda, Y1

Other Studies

1 other study available for gatifloxacin and Gastritis

ArticleYear
Disappearance of rectal mucosa-associated lymphoid tissue lymphoma following antibiotic therapy.
    Digestive diseases and sciences, 2004, Volume: 49, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Fluoroquinolones; Gastritis; Gatifloxacin; H

2004